Reine Allan bought PRME
February 26, 2026 · Form 4 insider transaction
Reine Allan bought 1,300,000 shares of Prime Medicine, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
1,300,000
Price
$0.00
Total value
N/A
InsiderReine Allan
Role—
CompanyPrime Medicine, Inc. (PRME)
SecurityStock Option (right to buy)
Transaction codeA: Grant or award
Transaction dateFebruary 26, 2026
Filing dateFebruary 27, 2026
Shares owned after1,300,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
1/48th of the shares underlying this option vest and become exercisable in substantially equal monthly installments on each monthly anniversary of February 26, 2026, subject to the Reporting Person's continued service on each such vesting date.